Objective The aim is to convert the functional prototype from FP7 PUMA project into a commercially-ready intelligent control system and to introduce this new solution for Pressure Ulcer (PU) prevention in the European Assistive Technologies market. The novelties of i-LiveRest are a) to measure PU risk in real time based on Tissue Viability (TV) with impedance, pressure, temperature and humidity textile sensors; and b) to decide the best combination of PU prevention strategies based on risk, user and context. It can be embedded on wheelchair and mattresses. i-LiveRest will be the first ICT solution applied to PU risk detection and prevention.PU are preventable but 38% of PU appear using current devices because a) risk, user status and context are not taken into account; and b) PU risk assessment is only based on pressure instead of TV. There is no available solution able to provide the functionalities of i-LiveRest.Target customers are Spinal Cord Injury (SCI) patients, healthcare public bodies and private insurances. On the one hand, SCI will develop a PU during their lifetime and 7-8% will die. i-LiveRest will increase their sitting time, enhancing their independent living. On the other hand, i-LiveRest will reduce public and private costs related to PU treatment (20 B€/year); injuries of professionals due to manual repositioning (2,000 M€/year); and will increase labour force of SCI and their relatives.In Phase 1, we need to: assess the technical and economic viability of industrialising i-LiveRest by optimising components; identify providers; prepare CE mark; identify purchasing agents; contact stakeholders; and elaborate a business plan. In Phase 2, we will optimise i-LiveRest system to reduce components size and costs, achieve CE mark and perform a pilot demonstration in four European countries.i-LiveRest is aligned with key EU global challenges: disability, independent living and job inclusion; reduction of social and health care costs; and increase of labour Fields of science medical and health scienceshealth sciencespublic healthengineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringcontrol systemsmedical and health sciencesclinical medicinephysiotherapysocial sciencessociologysocial issuessocial inequalitiesengineering and technologymaterials engineeringtextiles Programme(s) H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Topic(s) ICT-37-2015-1 - Open Disruptive Innovation Scheme (implemented through the SME instrument) Call for proposal H2020-SMEInst-2014-2015 See other projects for this call Sub call H2020-SMEINST-1-2015 Funding Scheme SME-1 - SME instrument phase 1 Coordinator QIMOVA AS Net EU contribution € 50 000,00 Address LILLE HAVDRUPVEJ 5 GI HAVDRUP 4622 Havdrup Denmark See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Danmark Sjælland Østsjælland Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 71 429,00
